"10.1371_journal.pmed.1001509","plos medicine","2013-09-03T00:00:00Z","Bertran Auvert; Dirk Taljaard; Dino Rech; Pascale Lissouba; Beverley Singh; Julie Bouscaillou; Gilles Peytavin; Séverin Guy Mahiane; Rémi Sitta; Adrian Puren; David Lewis","UMRS-1018, CESP, INSERM Villejuif, France; AP-HP, Hôpital Ambroise Paré, Boulogne, France; University of Versailles-Saint Quentin, Versailles, France; Progressus, Johannesburg, South Africa; National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa; AP-HP, Hôpital Bichat - Claude-Bernard, Paris, France; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa","Conceived and designed the experiments: BA. Performed the experiments: DT DR BS GP AP DL. Analyzed the data: BA PL JB GM RS. Wrote the first draft of the manuscript: BA. Contributed to the writing of the manuscript: BA DT DR PL BS JB GP GM RS AP DL. ICMJE criteria for authorship read and met: BA DT DR PL BS JB GP GM RS AP DL. Agree with manuscript results and conclusions: BA DT DR PL BS JB GP GM RS AP DL. Enrolled patients: DT DR.","GP has received travel grants, consultancy fees, honoraria, or study grants from various pharmaceutical companies including Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, Roche, Splicos, and ViiV Healthcare. GP is a member of different committees of the French National Agency for Research on AIDS and Viral Hepatitis (HIV Pharmacology, HIV Resistance, Therapeutic Strategy on HIV and Viral Hepatitis). All other authors have declared that no competing interests exist.","2013","09","Bertran Auvert","BA",11,FALSE,1,6,5,1,TRUE,TRUE,FALSE,0,NA,FALSE
